FDA Drug Approval Marks a First for a Disease — But It’s Not Autism / MedCity

Frank Vinluan / medcitynews - Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence.The post …

#healthcare #pharmaceuticals #publichealth #governmentpolicy #drugdevelopment #fda #autism

Clinicians divided amid growing demand for unproven autism drug

7 hrs / beckershospitalreview / Mariah Taylor

FDA Drug Approval Marks a First for a Disease — But It’s Not Autism

31 hrs / medcitynews / Frank Vinluan

FDA finds little evidence that a generic drug can help people with autism

6 days / medicalxpress

FDA widens use of leucovorin without new trial data

6 days / endpoints / Max Bayer

Sunday, March 15, 2026, 12:22 pm / permalink 20779 / 4 stories in 30 hrs

StackHealth Time Machine

Outgoing Stories

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 11 stories in 14.7 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 15.7 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 17.7 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 18.7 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 30.7 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 43.7 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 46.7 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 47.7 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 52.7 hours

AI improves UK breast-screening detection by about 10% 5 stories in 52.7 hours

More StackHealth

Bluesky: